Loading organizations...
§ Private Profile · 353 Hatch Drive, Foster City, CA 94404, United States
Biotechnology company developing liquid biopsy blood tests for oncology diagnostics, focused on early cancer detection and minimal residual disease.
Based in Toronto, Ontario, Adela is a biotechnology company that develops liquid biopsy blood tests utilizing a genome-wide methylome enrichment platform for early cancer detection and minimal residual disease monitoring. The firm's proprietary technology analyzes cell-free DNA to capture extensive genomic information from a single blood draw, eliminating the need for custom test development for individual patients. Currently available as a research use only assay, the platform serves biopharmaceutical companies engaged in oncology drug discovery and clinical development. To date, the enterprise has raised $108 million in total venture capital funding, which includes a recent $48 million financing round to advance its tissue-agnostic programs. This financial backing is supported by prominent institutional investors including OrbiMed, Labcorp, F-Prime Capital, and Deerfield Management. Adela was originally founded in 2020 by David Scheer, Maneesh Jain, Scott Bratman, and Daniel De Carvalho.
Adela has raised $108.0M across 2 funding rounds.
Adela has raised $108.0M in total across 2 funding rounds.
Adela has raised $108.0M in total across 2 funding rounds.
Adela's investors include Decheng Capital, Deerfield Management, F-Prime Capital, Shakti Ramkissoon, OrbiMed, RA Capital Management, Robert Weisskoff, F-Prime Capital Partners.
Adela has raised $108.0M across 2 funding rounds. Most recently, it raised $48.0M Other Equity in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 26, 2023 | $48M Venture Round | — | Decheng Capital, Deerfield Management, F Prime Capital, Shakti Ramkissoon, OrbiMed, RA Capital Management | Announced |
| Jun 1, 2021 | $60M Series A | Robert Weisskoff | F Prime Capital, Decheng Capital, Deerfield Management, OrbiMed, RA Capital Management | Announced |
Adela Technologies Inc. (AdelaTech) is a Maryland-based IT services company specializing in cloud security, managed services, DevSecOps, and AI/ML solutions to support organizations' digital transformations, particularly in regulated industries like defense, healthcare, finance, and energy.[1][2][4] It serves small businesses to enterprises by providing tailored consulting, vulnerability assessments, compliance automation, and continuous optimization, emphasizing secure, scalable infrastructure with a "born in the cloud" approach that integrates security from the outset.[1][3][4] The company was recognized as a top managed services provider in Maryland for 2023 by Clutch.co, focusing on reducing risk while accelerating software development and unlocking business insights via AI/ML.[1][7]
Adela Technologies emerged with a cloud-native foundation, starting its journey "born in the cloud" to deliver secure, scalable solutions amid the rise of cloud technologies and AI as transformative industry tools.[1][4] Based in Prince Frederick, MD, the company leverages deep experience from highly regulated sectors like defense, applying that expertise to help clients across healthcare, education, finance, e-commerce, and energy navigate digital shifts.[1][2][4] Key early traction includes partnerships like utilizing CoreSite’s hybrid IT for managed security services and Clutch recognition in 2023, underscoring its rapid positioning as a cybersecurity and IT consulting specialist for small businesses and beyond.[1][2][7]
AdelaTech rides the wave of accelerating digital transformation driven by cloud adoption, AI proliferation, and escalating cybersecurity threats, where regulated industries demand compliant, resilient infrastructure.[1][3][4] Its timing aligns with hybrid cloud demands—evident in partnerships like CoreSite for colocation with cloud onramps—enabling small businesses and enterprises to scale securely without heavy in-house expertise.[2] Market forces like rising data breaches, AI-enabled threat detection needs, and DevSecOps maturity favor its model, influencing the ecosystem by lowering barriers for non-tech-native sectors to adopt modern stacks, thus broadening secure cloud usage.[1][3][5]
AdelaTech is poised to expand its MSSP and AI/ML offerings as cyber threats evolve with AI and hybrid work, potentially deepening integrations in defense and healthcare amid stricter regulations.[1][3][4] Trends like zero-trust architectures and edge AI will shape its growth, amplifying influence through more awards, partnerships, and vertical expansions. This positions it to empower even more organizations in achieving risk-reduced digital agility, echoing its core mission of secure, cloud-born transformation.[1][2]